Low molecular weight heparin treatment of acute moderate and severe pancreatitis: A randomized, controlled, open-label study


Creative Commons License

Tozlu M., Kayar Y., İNCE A. T. , Baysal B., Şentürk H.

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.30, no.1, pp.81-87, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 1
  • Publication Date: 2019
  • Doi Number: 10.5152/tjg.2018.18583
  • Title of Journal : TURKISH JOURNAL OF GASTROENTEROLOGY
  • Page Numbers: pp.81-87
  • Keywords: Severe acute pancreatitis, moderately severe acute pancreatitis, low molecular weight heparin, pancreatic necrosis, complication, INFLAMMATION, ENCEPHALOPATHY, ACTIVATION

Abstract

Background/Aims: Acute pancreatitis (AP) runs a moderately severe and severe course in 20%-30% of cases. The purpose of the present study was to determine the effect of low molecular weight heparin (LMWH) for the prevention of pancreatic necrosis (PN) in moderately severe and severe AP (MSAP).